Capital Reduction::Mandatory

Issuer & Securities

Issuer/ Manager
AXINGTON INC.
Security
AXINGTON INC. - MYA012218006 - 42U

Announcement Details

Announcement Title
Capital Reduction (Impacts shareholder)
Date &Time of Broadcast
10-Aug-2022 22:22:56
Status
New
Corporate Action Reference
SG220810DECROQEP
Submitted By (Co./ Ind. Name)
Ang Chiang Meng
Designation
Executive Director
Cash Payout
Yes
Current Share Capital
14,342,289
New Share Capital
2,438,917
Financial Year End
31/12/2021

Event Narrative

Narrative Type
Narrative Text
Additional TextPlease refer to attached announcement in relation to the proposed cancellation of 3,750,000 ordinary shares held by Kerrigan Medical Supplies Pte. Ltd., the proposed reduction of share capital by
S$11.903 million and the proposed dividend of S$14.097 million.
Additional TextThis announcement has been prepared by the Company and reviewed by the Company's sponsor, Novus Corporate Finance Pte. Ltd. ("Sponsor"), in compliance with Rule 226(2)(b) of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist.
Additional TextThis announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made, or reports contained in this announcement.
Additional TextThe contact person for the Sponsor is Mr. Pong Chen Yih, Chief Operating Officer, at 7 Temasek Boulevard, #18-03B Suntec Tower 1, Singapore 038987, telephone (65) 6950 2188.

Event Dates

Record Date and Time
18/08/2022 17:00:00
Ex Date
17/08/2022

Disbursement Details

Cash Payment Details
Offer Price
SGD 0.1393
Pay Date
25/08/2022
Outstanding Securities Redeemed (%)
82.994925008

Attachments